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Abstract
Background: Cementless fixation of total hip arthroplasties (THAs) is often favored in young, high-demanding
patients due to the conservation of valuable bone-stock and easier revision if loosening has occurred. Long-term
outcome data of the spongy metal structured implant used in the present study in patients younger than 65 years
are still lacking.
Methods: We conducted a retrospective chart review and functional investigation (Merle d’Aubigné score, SF-12)
of patients younger than 65 years at implantation treated with a spongy metal structured THA (n = 79) from one
orthopedic university center from 1985 to 1989.
Results: At a 19-year mean follow-up (range: 15.3 – 21.3 years), the overall stem survival rate was 93.7 %, and the
overall cup survival rate was 82.3 %. Revision surgeries of the stem were performed in all cases for aseptic loosening at
an average of 15.3 ± 3.5 years after implantation. Acetabular components were revised for aseptic loosening and
recurrent dislocation after inlay revision on an average of 11.8 ± 4.7 years after implantation. No other device related
complications occurred within the 19-year follow-up period. No correlation was found between time of revision and
gender or age. Clinical outcome scores (Merle d’Aubigné score, SF-12) revealed excellent to good results of the
implanted THAs in 87 % of patients.
Conclusions: We conclude that spongy metal structured cementless THAs implanted in young patients have an
excellent survival and provide trustworthy clinical results at 19 years of follow-up.
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Background
Total hip arthroplasty (THA) is one of the most successful
surgical interventions ever developed. Results of cemented
THAs showed lasting pain relief and a survivorship of
more than 80 % at 20 years after surgery, however some
negative predictive factors were identified that contribute
to success or failure of the procedure [1]. In a 25-year
follow-up study Berry et al. described that the survivorship
free of revision for aseptic loosening was poorer for each
decade earlier in life at which the procedure was
performed [2]. They found that survivorship rate was
68.7 % in patients younger than 40 years compared to
100 % in patients aged 80 years and older. Males had a
twofold higher rate of revision for aseptic loosening as
compared to females.
Technical evolution of cementless fixation implants
with regards to surface structure, shape and metallurgic
aspects has led to higher survival rates [3]. For long-
term stability, bony anchorage of the implant should
achieve specific parameters. Meso-structure surfaces in
which pore size and depth copy cancellous bone
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morphology provide a unique feature on implants with
direct bone contact [4]. Pore size of 100-2000 μm, and
porosity larger than 40 % has been shown to favour
osseous integration [5]. High form fit to the inner
osseous structure and high primary stability with micro-
movements less than 150 μm are also necessary for bony
anchorage and high secondary long-term stability [6]. In
this context implants have been developed with surface
structures similar to that of human cancellous bone. By
the use of a special wax molding process full porous
implant surface cast in one piece with its core is
achieved, allowing for a fully integrated core-surface
structure (Fig. 1). This kind of integration allows for
pore size to be between 800-1500 μm and depth reach-
ing up to 3000 μm with an overall porosity of 60 % [4].
It also allows the formation of mesh spaces, forming an
intercommunicating system extending throughout the
surface of the implant.
The aim of the present study was to assess the long-term
outcome in patients younger than 65 years after cementless
THA with first generation spongy metal implants.
Methods
This study was reviewed and approved by the Medical
Ethical Committee at the Klinikum rechts der Isar
(Technical University of Munich) and research was
carried out in compliance with the Helsinki Declaration.
Written informed consent was obtained from all patients
included in the study.
One hundred consecutive cementless THAs were
performed in 88 patients during the period between
1985 and 1989 using a spongy metal structured
implant (ESKA/AQ Implants, stem-type GHE, Lübeck,
Germany). All patients were prospectively enrolled in
the study. Written informed consent was obtained
from all patients. The mean age of the patients at
time of surgery was 47 years (range: 18 to 65 years),
with 51 males and 49 females out of 100 THAs. 49
right, and 51 left hip arthroplasties were performed.
The implant used was an anatomically adapted, side
specific anatomical double curved stem and hemispher-
ical cup, with fully porous metal surface, that resembles
cancellous bone (Fig. 1). The spongy metal structured
surface has a porosity of 60 % and a pore size from 800-
1500 μm. Two spikes wedged into the anterior and
posterior parts of the acetabular rim and a peg embed-
ded into the ischium assist in the initial stability of the
metal socket. Minor changes of the stem design
(removal of the collar, partially coated stem with new
developed surface structure “Spongiosa Metal®-II”) were
conducted after the inclusion period of the present study
(Fig. 2). The GHE stem and metal socket of the implant
are produced in a casting process using an alloy of
chrome, cobalt and molybdenum. The metal backed
articular surface is made of standard polyethylene.
28 mm ceramic heads were used in all patients. All
components were sterilized using gamma irradiation in
vacuum seal atmosphere.
All surgeries were performed in one specialized
arthroplasty medical centre by senior surgeons using a
posterior approach [7]. The patient was placed in a true
lateral position, with the affected limb uppermost. A
10-15 cm curved incision across the buttock centered on
the posterior aspect of the greater trochanter was
performed. The gluteus maximus was split in the line of
its fibers, crossing vessels were coagulated. The short
external rotator muscles were dissected from their
femoral insertion and retracted laterally so that the
sciatic nerve was protected. The capsule was incised and
Fig. 1 Spongy metal surface implant GHE
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the hip dislocated in maximum adduction and internal
rotation. The femoral neck was resected to gain good ac-
cess to the acetabulum. After placing the retractors, the
acetabulum was reamed according to the desired diameter,
the cup was placed with 40-40° inclination and 10-15°
anteversion. To finish with the cup the inlay was inserted.
Then the retractors were placed to gain good view to the
femoral canal, and the stem was rasped to the desired size.
Finally the stem was inserted and the final head placed
after determining the exact leg length through dislocation
tests with the provisional head in place.
Postoperatively, physiotherapy was conducted for the
first 3 months. It consisted of exercises aimed for
increasing circulation to the legs and feet to prevent
thrombosis. Muscle strengthening and mobilization of the
hip was a focus of the therapy. Patients were allowed to
perform exercises in the water after removal of stitches.
According to the past standard partial weight bearing
within the first 6 weeks after surgery was allowed.
Patients were routinely followed 6-8 weeks postopera-
tively and then at final follow up. Due to the distance
from the patients’ home and the clinic, not all patients
were followed annually as it would be in accordance to
the clinic’s standard.
Radiological evaluation was conducted of the operated
side(s) in an anteroposterior and lateral view. X-rays
were taken routinely immediately after implantation and
at least at final follow-up visit. The radiographic criteria
evaluated were bone atrophy, bone hypertrophy, radio-
lucent lines, osteolysis, and component subsidence [8].
A relative increase or decrease in cortical bone mass or
density at latest follow-up versus the first postoperative
radiographs was defined as bone hypertrophy or atrophy.
Radiolucent lines were defined as lucencies at the bone-
prosthesis interface with or without a sclerotic line.
Osteolysis was defined as scalloping of bone that was
not present on the first postoperative radiograph.
Component subsidence was determined by measuring
implant position relative to the tip of the greater tro-
chanter (stem subsidence) or tear drop (cup subsidence)
compared with that of the first postoperative radiograph.
Deviation greater than 1 mm was considered significant.
Functional outcome was measured using the Merle
d’Aubigné rating system [9]. Additionally, subjective
clinical outcome was measured using MacNab’s outcome
assessment of patient satisfaction [10]. The patient was
asked to rate his general level of well-being after surgery:
Excellent (no pain; no restriction of activity), Good
(occasional hip pain of sufficient severity to interfere
with the patient’s ability to do his normal work or his
capacity to enjoy himself in his leisure hours), Fair
(improved functional capacity, but handicapped by
intermittent pain of sufficient severity to curtail or
modify work or leisure activities), Poor (no improvement
or insufficient improvement to enable increase in activ-
ities). Pain was scored on the 10-cm visual analogue
scale (VAS). Furthermore, global outcome including
mental and physical health was assessed by the SF-12
short form questionnaire. The mean follow-up time was
19 years (range 15.3-20.3 years) at the final assessment.
Statistical analysis
Statistical evaluation and analysis were performed using
SPSS 21.0 software (IBM SPSS, Armonk, NY). Survivor-
ship analysis using Kaplan-Meier was carried out with
revision for any reason as the end point. Statistical
analysis of Merle d’Aubigné score and SF-12 was carried
Fig. 2 Modified GHE-implant with no collar and spongy metal sur-
face (Spongiosa Metal®-II, see magnification) at the stem body and
smooth surface at the distal portion
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out using the paired t-test (significance level: 0.05). A
power analysis revealed a total sample size of 26 (two
independent study groups; dichotomous primary
endpoint: failure vs. no failure; anticipated incidence of
failure: 24 %; anticipated incidence of failure free
survival: 76 %; alpha: 5 %; beta: 20 %; power: 80 %).
Results
At the time of the last follow-up 93 out of 100 hips
could be evaluated (84 out of 88 patients). No data could
be retrieved from 7 hips (4 patients). 2 patients were lost
to follow-up (address unknown) and 2 subjects moved
to other countries and refused to participate in the
study. From the remaining 84 patients (93 hips) 8
patients (14 hips) had died without change or revision of
the THA at 14.1 ± 4.3 years after surgery (Fig. 3).
79 remaining hips (76 patients, 41 males and 35
females) were enrolled in the final analysis (follow-up
rate of 79 %). The mean age of the evaluated patients at
the final follow-up was 64.8 ± 9.4 years (38 - 83 years)
with a mean weight of 78.6 ± 17.0 kg (51 - 133 kg), mean
height of 170.1 ± 8.9 cm (152 - 190 cm) and a mean body
mass index (BMI) of 27.0 ± 4.4 kg/m2 (19.1 - 38.5 kg/m2).
The diagnoses that had led to the THA are given in Table 1.
The overall stem survival rate at follow-up was 93.7 %
(Fig. 4). Revision of the stem was performed in 5 cases
15.3 ± 3.5 years after implantation (10.4 – 17.8 years) for
aseptic loosening in all cases. 14 acetabular components
were revised after 11.8 ± 4.7 years (2.6 – 18.5 years). Fi-
nally, the overall cup survival rate was 82.3 % after
19 years (Fig. 5). The reasons leading to revision of the
socket were recurrent dislocation after inlay revision due
to wear in 2 patients, aseptic loosening in 8 cases and a
combined inlay and head revision was required due to
wear in 4 hips. No other device related complications oc-
curred within the 19-year follow-up period. No correlation
was found between time of revision and gender or age.
Regarding radiological evaluation, all hips without
revision showed signs of bone atrophy, bone hyper-
trophy, radiolucent lines, and osteolysis. No hip showed
component subsidence, neither of the acetabular nor the
femoral component.
The excellent results found in the Merle D’Aubigné
Score (Table 2) were confirmed on the MacNab’s out-
come assessment score. 19 years after THA, 60 % of the
evaluated patients were classified as excellent, 27 % as
Fig. 3 Patient distribution of the total cohort
Table 1 Diagnoses leading to THA of study population
Diagnosis Number of patients (%)
Hip Dysplasia 25 (32 %)
Epiphyseal Varus Deformity 14 (18 %)
Idiopathic Avascular Necrosis 12 (15 %)
Posttraumatic Avascular Necrosis 10 (13 %)
Rheumatoid Arthritis 3 (4 %)
Cortisone Induced Avascular Necrosis 3 (4 %)
Perthes Disease 3 (4 %)
Alcohol Induced Avascular Necrosis 2 (3 %)
Primary Osteoarthrosis 7 (9 %)
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good, 12 % as moderate and 1 % as poor. An excel-
lent or good result was therefore observed in 87 %.
Furthermore, 96 % of all patients would recommend
the procedure of THA to a friend. Regarding clinical
outcome scores, no differences were found relating to
the patient’s gender.
Evaluation of SF-12 questionnaires revealed a mean
physical sum score of 45.74 (median 49.33), and a mean
mental sum score of 50.24 (median 53.37). Thus, with
respect to the mean physical sum score the patients
were only marginally less healthy compared to a general
US population (mean 50.0). The differences in SF-12
Fig. 4 Kaplan-Meier survival curve of survival to stem-revision for any reason, with a survival of 93.7 % after 19 years of follow-up
Fig. 5 Kaplan-Meier survival curve of survival to socket-revision for any reason, with a survival of 82.3 % after 19 years of follow-up
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score values between patients with revision and without
revision were not statistically significant.
Discussion
Biological fixation of the implants by bone ingrowth is
thought to be essential for the long-term success of a
cementless THA. Stems which are porous-coated only in
their proximal part have become popular. The more
proximal stress transfer is believed to help prevent stress
shielding, with less corrosion and release of metal ions,
and easier removal of the implant if needed. There have
been problems, however, with thigh pain and the early
failure of the femoral component [11]. Even after there
has been bone ingrowth into a limited part of the porous
surface, partial porous coating may not provide sufficient
stability. The spongy metal system examined in the
present study provides excellent biologic anchorage due
to the specific design of the structured surface. In
contrast to porous coated surfaces, an interconnecting
open structured design is used to achieve excellent
structure compatibility. Porosity provides bony ingrowth
but has to have a certain size which was calculated to be
at least 40 % [4]. The second specification representing a
significant impact on bony ingrowth is defined as porous
size. If the pore size is less than 100 μm only soft tissue
formation around the surface is observed, corresponding
to elastic fibrous fixation of the implant. Several clinical
studies found excellent survival rates if spongy metal
structured implants were used. Matsui published a series
of 49 patients in 1998 [12]. Excellent to good functional
outcome was found in all patients after 5 to 9 years. No
aseptic loosening was reported. Three out of 49 patients
had thigh pain after surgery which disappeared within
the first 2 years postoperatively. These mid-term results
were confirmed by other authors [13]. On the other
hand, long-term data regarding spongy metal structured
implants are lacking. Therefore, the present study is the
first to show high survival rates and excellent to good
functional results in the long-term follow-up 19 years
after surgery. Overall GHE stem survival was 93.7 %
(Fig. 4), acetabulum component survival was 82.3 %
(Fig. 5). Additionally, we could not find any correlation
between clinical outcome and BMI. Similar results were
reported by McLaughlin et al. who found no statistically
significant difference between obese and non-obese
patients with regards to clinical and radiological out-
come or complications [14].
Our results suggests that use of cementless spongy
metal fixation in primary THA in young patients is asso-
ciated with low implant failure rates. On the other hand,
there is only limited evidence regarding this topic. A
meta-analysis of 20 studies using stratified and regres-
sion methods found no difference between fixation of
THA with and without cement when revision of either
component or both components was used as the study
end-point. The sub-group analysis however demon-
strated a trend toward superior results in younger
patients who were managed with cementless fixation
[15]. In studies of patients aged less than 45 years at the
time of implantation, White et al. reported a revision
rate of 14 % at 7.5 years [16]. Dorr et al. reported a
revision rate of 19 % at only 4.5 years, with 45 % of the
surviving implants showing radiologic signs of impend-
ing failure [17]. Sharp and Porter reported a 14 %
revision rate at 6 years in patients aged less than 40 years
and implicated rheumatoid arthritis as the main cause of
loosening [18]. Williams and McCullough reported
loosening in 24.6 % of hips at 4.5 years, but in 43.5 % of
implants that had been in place longer than 5 years [19].
A large cross sectional study of Charnley-THA was
published by Allami et al. [20]. The authors demonstrated
a cumulative survival rate of 93.1 % at 10 years, the overall
outcome was therefore comparable to those from the
Swedish and Norwegian joint registries. Recent data from
joint registries support these findings (Table 3) [21].
Table 2 The functional outcome (Merle d’Aubigné) score
regarding the item pain, mobility, and ability to walk
Item Preoperatively At final follow-up
Pain 2.70 ± 0.77 5.24 ± 1.15*
Mobility 3.59 ± 1.23 4.76 ± 1.32*
Ability to walk 3.19 ± 0.94 to 5.00 ± 1.32.*
Total score 9.47 ± 2.0 15.0 ± 3.1*
*p < .05
Table 3 Distribution of fixation methods (cementless: uncementd
THA; cemented: cup and stem cemented; hybrid: cup cementless,
stem cemented; reverse hybrid: cup cemented, stem cementless)
according to country, and 10-year age- and fixation-matched
survival analysis based on registry data
Cementless Cemented Hybrid/reverse hybrid
Registry Fixation [%]
Australia 64 5 31
Sweden 15 68 17
Denmark 68 16 16
Norway 20 53 27
New Zealand 45 14 41
England and Wales 46 33 21
Spain 70 10 20
Canada 83 1 16
Age (years) 10 years Survival-rate [%]
<65 92.2 93.5 93.5
65-7 93.1 94.1 94.2
>75 91.2 94.1 94.3
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Focusing on the acetabulum site, fixation technique is
discussed controversially. Callaghan et al. have reported
the long-term results of cemented THAs with 13 %
aseptic loosening at 19 years [22]. The aseptic loosening
rate increases up to 52 % if the population younger than
50 years is reviewed [23]. The poor results of cemented
acetabular components prompted many surgeons to
change technique to cementless implants with biologic
fixation and acetabular bony ingrowth. Marshall et al.
eported on a cementless system series [24]. Seventy-four
hips underwent revision of the acetabular component.
Of these 74 % were threaded acetabular components
and 26 % had a porous hemispherical cup with adjuvant
screws. Midterm results showed significant improvement
over cemented acetabular shells. The authors conclude
that lower rates of aseptic loosening provides a scientific
justification to favour biologic fixation for the acetabular
component, especially in younger patients.
The optimal method to obtain femoral fixation
remains controversial as well. In contrast to the acetabu-
lum site the results of cemented and cementless femoral
fixation are comparable. Excellent long-term results have
been observed for cemented and cementless stems [1, 25].
Poor short-term results have been observed for both
methods of fixation as well [15]. A significant risk factor
in this context are high demanding, active patients. In this
context, a study reports revision rates of 34 % (socket) and
23 % (stem) if a cemented Charnley-THA-System was
used in patients younger than 30 years [26]. Alternative
methods of fixation have therefore been explored in this
population [27].
Conclusion
In summary, our findings of the excellent long-term
outcome after primary spongy metal surface THA in
young patients demonstrate the effectiveness of cement-
less implants if required specifications are respected.
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